BRPI0508941A - método de vacinação contra infecção de bvdv testicular - Google Patents

método de vacinação contra infecção de bvdv testicular

Info

Publication number
BRPI0508941A
BRPI0508941A BRPI0508941-7A BRPI0508941A BRPI0508941A BR PI0508941 A BRPI0508941 A BR PI0508941A BR PI0508941 A BRPI0508941 A BR PI0508941A BR PI0508941 A BRPI0508941 A BR PI0508941A
Authority
BR
Brazil
Prior art keywords
infection
vaccination method
method against
bvdv infection
against testicular
Prior art date
Application number
BRPI0508941-7A
Other languages
English (en)
Inventor
Michael Aaron Ellsworth
Cassius Mcallister P Tucker
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of BRPI0508941A publication Critical patent/BRPI0508941A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

MéTODO DE VACINAçãO CONTRA INFECçãO DE BCDV TESTICULAR. Os métodos da invenção referem-se a métodos para prevenir a infecção testicular pelo vírus da diarréia viral bovina pela imunização de animais machos suscetíveis contra a infecção.
BRPI0508941-7A 2004-03-17 2005-03-04 método de vacinação contra infecção de bvdv testicular BRPI0508941A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55386704P 2004-03-17 2004-03-17
PCT/IB2005/000610 WO2005089793A1 (en) 2004-03-17 2005-03-04 Method of vaccination against testicular bvdv infection

Publications (1)

Publication Number Publication Date
BRPI0508941A true BRPI0508941A (pt) 2007-08-14

Family

ID=34961163

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0508941-7A BRPI0508941A (pt) 2004-03-17 2005-03-04 método de vacinação contra infecção de bvdv testicular

Country Status (23)

Country Link
US (1) US20080260778A1 (pt)
EP (1) EP1727562B1 (pt)
JP (1) JP4105220B2 (pt)
KR (2) KR20060127199A (pt)
CN (1) CN1929859A (pt)
AR (1) AR048671A1 (pt)
AT (1) ATE398462T1 (pt)
AU (1) AU2005224179B2 (pt)
BR (1) BRPI0508941A (pt)
CA (1) CA2560532A1 (pt)
DE (1) DE602005007584D1 (pt)
DK (1) DK1727562T3 (pt)
ES (1) ES2306101T3 (pt)
NO (1) NO20063603L (pt)
NZ (1) NZ549592A (pt)
PL (1) PL1727562T3 (pt)
PT (1) PT1727562E (pt)
RU (1) RU2335298C2 (pt)
SI (1) SI1727562T1 (pt)
TW (1) TWI306404B (pt)
UA (1) UA86405C2 (pt)
WO (1) WO2005089793A1 (pt)
ZA (1) ZA200607132B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY29915A1 (es) * 2005-11-15 2007-06-29 Boehringer Ingelheim Vetmed Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina
ES2606605T3 (es) * 2010-09-21 2017-03-24 Intervet International B.V. Vacuna para el BVDV
AR084358A1 (es) 2010-12-27 2013-05-08 Lilly Co Eli Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc))
EP2658570B1 (en) * 2010-12-27 2018-11-28 Elanco US Inc. Bovine viral diarrhea virus type 1b vaccine compositions and methods
US9480739B2 (en) * 2013-03-15 2016-11-01 Intervet Inc. Bovine virus vaccines that are liquid stable
CN107823639B (zh) * 2017-11-10 2020-10-02 齐鲁动物保健品有限公司 牛病毒性腹泻病毒灭活疫苗及其制备方法
WO2025172363A1 (en) * 2024-02-12 2025-08-21 Hipra Scientific, S.L.U. Vaccine against bovine viral diarrohea virus and bovine respiratory disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593873A (en) * 1986-01-27 1997-01-14 Syntro Corporation Recombinant infectious bovine rhinotracheitis virus
US5709865A (en) * 1994-11-10 1998-01-20 Biostar Inc. Immunogenic composition against Bovine Viral Diarrhea Virus II glycoprotein 53 (BVDV-II gp53)
US6001613A (en) * 1996-05-24 1999-12-14 Board Of Regents Of University Of Nebraska Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid
US6174667B1 (en) * 1997-09-23 2001-01-16 Cornell Research Foundation, Inc. Bovine viral diarrhea virus serum antigen capture
US6606457B2 (en) * 2001-06-19 2003-08-12 Pentax Corporation Focused image tremble correcting device
AU2002356520A1 (en) * 2001-08-09 2003-03-18 Cornell Research Foundation, Inc. Detection of bovine viral diarrhea virus in tissue samples

Also Published As

Publication number Publication date
EP1727562B1 (en) 2008-06-18
PL1727562T3 (pl) 2008-10-31
UA86405C2 (ru) 2009-04-27
CA2560532A1 (en) 2005-09-29
SI1727562T1 (sl) 2008-10-31
KR20080036160A (ko) 2008-04-24
JP4105220B2 (ja) 2008-06-25
KR20060127199A (ko) 2006-12-11
EP1727562A1 (en) 2006-12-06
JP2007529498A (ja) 2007-10-25
WO2005089793A1 (en) 2005-09-29
TW200531701A (en) 2005-10-01
TWI306404B (en) 2009-02-21
ZA200607132B (en) 2008-08-27
NZ549592A (en) 2008-12-24
DE602005007584D1 (de) 2008-07-31
ATE398462T1 (de) 2008-07-15
NO20063603L (no) 2006-09-08
AU2005224179B2 (en) 2007-08-23
AU2005224179A1 (en) 2005-09-29
PT1727562E (pt) 2008-09-05
ES2306101T3 (es) 2008-11-01
DK1727562T3 (da) 2008-09-15
AR048671A1 (es) 2006-05-17
RU2335298C2 (ru) 2008-10-10
US20080260778A1 (en) 2008-10-23
CN1929859A (zh) 2007-03-14
RU2006133328A (ru) 2008-03-27

Similar Documents

Publication Publication Date Title
CY1126231T1 (el) Παραλλαγες ανθρωπινης αλφα-γαλακτοσιδασης
ECSP066683A (es) Vacuna para mejorar el crecimiento, a base de epítopes neutralizantes
WO2006133879A3 (en) Vaccines for immunization against helicobacter
EA201791907A1 (ru) Бивалентная вакцина против вируса свиного гриппа
WO2009034315A3 (en) Vaccine
EA201991041A1 (ru) Вакцина против свиного парвовируса и вируса свиного репродуктивного и респираторного синдрома и способы ее получения
GEP201706766B (en) Methods and compositions for vaccinating against staphylococcus aureus
CY1107188T1 (el) Εμβολιο ε. coli πτηνου για την προστασια εναντι κολοβακτηριωσης
ECSP077179A (es) Co-cultivos manejados de organismos que tienen efectos profilacticos y promotores de la salud
MD20190080A2 (ro) Forme cristaline de (s)-afoxolaner
BR112017003462A2 (pt) coronavírus bovino atenuado, vacina, e, método de vacinação de um bovino.
WO2007098717A3 (es) Antígenos vacunales quiméricos contra el virus de la peste porcina clásica
EA202192251A1 (ru) Вакцина для защиты от streptococcus suis
DE60336927D1 (pt)
WO2007140244A3 (en) Vaccination of young animals against lawsonia intracellularis infections
MX2012003827A (es) Toxina rtx citolitica de gallibacterium anatis.
ECSP099066A (es) Vacuna combinada estreptococica
EA201792593A1 (ru) Пестивирусные вакцины против врожденного тремора
EP4349367A3 (en) A vaccine for protection against streptococcus suis
TW200531701A (en) Method of vaccination against testicular BVDV infection
BRPI0514053A (pt) método para aumentar a tolerabilidade das plantas frente ao glifosato
BRPI0520510A2 (pt) composições antimicrobiais e seus processos associados
ATE526034T1 (de) Verbesserte inaktivierte fcv-vakzinen
BRPI0713274A2 (pt) combinação de vacinas para a proteção de peixes contra a infecção estreptocócica, e, método para a preparação de uma combinação de vacinas
MX2009000717A (es) Composicion para vacuna y metodo para inmunizacion.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.